Vesalio’s enVast Meets NATURE Trial Endpoint in STEMI
Dallas, Texas, August 29, 2026 Vesalio announced positive results from the NATURE randomized controlled trial, evaluating the company’s enVast™...
Cardiology
Advertisement
Tenax Therapeutics Reports LEVEL Data at ESC Congress 2026
Tenax Therapeutics, Chapel Hill, North Carolina, August 29, 2026 Tenax Therapeutics announced the presentation of additional Phase 3 LEVEL...
Cytokinetics Highlights Phase 3 Aficamten Data at ESC
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2026 Cytokinetics, Incorporated announced additional clinical data for aficamten from the ACACIA-HCM and...
Bristol Myers Squibb Reports Five-Year Camzyos Data
PRINCETON, N.J., August 26, 2026 Bristol Myers Squibb presented new long-term data for Camzyos® (mavacamten) at the European Society...
BridgeBio Pharma Reports New Acoramidis Data at ESC 2026
PALO ALTO, Calif., August 30, 2026 BridgeBio Pharma, Inc. presented new data from the Phase 3 ATTRibute-CM study of...
Advertisements
GE HealthCare Advances Cardiac Ultrasound With AI-Enabled Vivid Imaging Systems
Chicago, Ill. – August 28, 2026 GE HealthCare announced three additions to its Vivid™ cardiovascular ultrasound portfolio — Vivid...
Catheter Precision Secures LockeT Orders and First German VIVO Placement
Fort Mill, S.C. – August 27, 2026 Catheter Precision, Inc. announced several commercial milestones for its LockeT® and VIVO™...
Curium to Merge with Lantheus in $8B Radiopharma Deal
Boston & Bedford, Massachusetts, August 3, 2026 Curium and Lantheus Holdings, Inc. have entered into a definitive merger agreement...
Haemonetics Study Validates VASCADE MVP XL Performance
Boston, Massachusetts, August 3, 2026 Haemonetics Corporation has announced the publication of a major real-world clinical study providing additional...
Lexicon Pharmaceuticals Completes Enrollment in Phase 3 SONATA-HCM Trial
THE WOODLANDS, Texas, July 27, 2026 Lexicon Pharmaceuticals, Inc. announced the completion of patient enrollment and randomization in the...
Advertisement
